AcuraStem Inc

AcuraStem Inc. is a privately-held company located in Pasadena, California. Employing 26 individuals, the company focuses on pioneering drug discovery and treatment development for neurodegenerative diseases. AcuraStem's innovative approach centers around its iNeuroRx® technology platform, which enables the development of drug candidates with the potential to significantly impact disease progression. AcuraStem specializes in developing treatments for various neurodegenerative diseases, including sporadic ALS and FTD. The company's focus extends to addressing the complexities of these diseases, particularly those without a known genetic cause. AcuraStem's drug candidates are designed to provide effective treatment options for a broad range of patients, regardless of their genetic profile. AcuraStem differentiates itself through its patient-based approach and a unique technology platform. Its iNeuroRx® technology empowers the discovery and advancement of groundbreaking drug candidates that hold promise for treating a wide spectrum of neurodegenerative diseases. For more information about AcuraStem's innovative work and therapeutic programs, please visit their website at acurastem.com.